About Mercury Data Science: MDS is a full-stack AI product development partner. Our team is multidisciplinary, bringing technology and perspectives from neuroscience, physics, engineering, computational biology, genomics, and computer science. We develop AI strategies around Machine Learning and Natural Language Processing and enable our clients to deploy scalable AI solutions

Stream Biomedical is an early stage company founded to address unmet therapeutic needs for individuals suffering as a result of neurologic trauma and/or degeneration. We are seeking a Process Development & Manufacturing Manager, Biotech to support development activities. Candidate should be entrepreneurial, resourceful and interested to work with multiple internal

GlycosBio Food Sciences develops novel nutritional and drug delivery systems based on the company’s proprietary Enzyme Modified Oil (EMO) platform. These products can benefit healthy individuals and patients with a variety of maldigestion/malabsorption conditions. The Senior Scientist position reports to the VP of R&D and will be engaged in laboratory

Organization H0238 Office of Tech Management  Description Evaluates and analyzes market potential, conducts patent searches for new invention disclosures and provides general office and technical support in intellectual property management. Drafts and negotiates new and amended technology transfer agreements and monitors existing agreements to ensure compliance with contract terms. Documents

Stream Biomedical is an early stage company founded to address unmet therapeutic needs for individuals suffering as a result of neurological trauma and/or degeneration.  We are seeking an energetic Project Manager to support development activities. Candidate should be entrepreneurial, resourceful and interested to work with multiple internal and external disciplines.

Company Info: Asylia Therapeutics Inc., is a new biotech start-up founded by seasoned entrepreneurs to develop novel antibody drugs targeting the fundamental mechanisms governing immunity in cancer and autoimmune disease. Fueled by investments from a world-class investor syndicate led by Sporos Bioventures, Asylia’s platform centers on a drug pipeline capable